CompanyPASGNasdaqPhiladelphia, PA

Passage Bio, Inc.

Passage Bio develops genetic medicines for neurodegenerative diseases.

SEC EDGAR ClinicalTrials.gov investors.passagebio.com

8-KSep 3Latest SEC filing, period to Sep 2

Sep 2Latest story

September 2026

Passage Bio and Remix amend merger deal into two-step structure

Sep 2PartnershipPassage Bio, Inc.